New consensus guidelines for the effective dosing of vancomycin were released in March 2020—just as the first wave of the pandemic upended healthcare as we know it. In light of the changes and challenges facing clinical pharmacists, how likely are they to adopt these new guidelines quickly?
Data from a recent market study shows that, while pharmacists agree that these guidelines are important for patient safety, only a minority have plans to adopt them.
To discuss what’s driving pharmacists’ decisions, a panel-based webinar will dig deep into the data, and share insights on how precision dosing can make a meaningful impact on patient safety.
